UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000053783 |
|---|---|
| Receipt number | R000061379 |
| Scientific Title | Continuation rates and physicians' perceptions on tinea pedis management in Japan: a web-based survey and prescription analysis |
| Date of disclosure of the study information | 2024/03/05 |
| Last modified on | 2024/03/05 15:02:05 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Continuation rates and physicians' perceptions on tinea pedis management in Japan: a web-based survey and prescription analysis
Acronym
Continuation rates and physicians' perceptions on tinea pedis management in Japan: a web-based survey and prescription analysis
Scientific Title
Continuation rates and physicians' perceptions on tinea pedis management in Japan: a web-based survey and prescription analysis
Scientific Title:Acronym
Continuation rates and physicians' perceptions on tinea pedis management in Japan: a web-based survey and prescription analysis
Region
| Japan |
Condition
Condition
Tinea pedis
Classification by specialty
| Dermatology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To understand the reality of prescription continuation for tinea pedis and physicians' perceptions regarding their drug selection for tinea pedis
Basic objectives2
Others
Basic objectives -Others
Not applicable
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
The reality of prescription continuation for tinea pedis and physicians' perceptions and intentions regarding their drug selection for tinea pedis
Key secondary outcomes
Not applicable
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
1. Dermatologists who practice tinea pedis treatment
Key exclusion criteria
[Physician Survey] Physicians who do not meet the inclusion criteria
Target sample size
200
Research contact person
Name of lead principal investigator
| 1st name | YUICHIRO |
| Middle name | |
| Last name | TSUNEMI |
Organization
Saitama Medical University
Division name
Dermatology
Zip code
350-0495
Address
38 Morohongo, Moroyamamachi, Irumagun, Saitama 350-0495 Japan
TEL
049-276-1111
ytsun-tky@umin.ac.jp
Public contact
Name of contact person
| 1st name | ETSUKO |
| Middle name | |
| Last name | IWASHITA |
Organization
QLife Inc.
Division name
Patient Recruitment Dept
Zip code
105-0001
Address
Toranomon 33 Mori-Bld.10F 3-8-21, Toranomon, Minato-Ku, Tokyo 105-0001 Japan
TEL
03-6860-5020
Homepage URL
e-iwashita@qlife.co.jp
Sponsor or person
Institute
Other
Institute
Department
Personal name
Funding Source
Organization
Sato Pharmaceutical Co.,Ltd
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Not applicable
Name of secondary funder(s)
IRB Contact (For public release)
Organization
The Ethics Committee of Noguchi Dermatology Clinic
Address
964-1, Uejima, Kashima-machi, Kamimashiki-gun, Kumamoto, 861-3106 Japan
Tel
096-237-4112
derma@nogcli.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2024 | Year | 03 | Month | 05 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2024 | Year | 02 | Month | 14 | Day |
Date of IRB
Anticipated trial start date
| 2024 | Year | 03 | Month | 05 | Day |
Last follow-up date
| 2024 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
This study will collect data through a web-based physician survey.
The data to be collected is indicated in the "Assessment" section.
Additionally, a prescription survey will be conducted on the continuation of treatment with tinea pedis medications.
[Prescription Survey]
The prescription survey will extract and aggregate receipt data (National Medical Data: NMD) from medical institutions contracted with the International Research Institute of Medical Strategy, Ltd.
Survey period: January 2022 - December 2023
Subjects: Patients prescribed drugs indicated for tinea pedis from January 2022 to June 2023
(Notes: patients who were prescribed a treatment indicated for tinea pedis in the 6 months immediately preceding the period are excluded.)
Management information
Registered date
| 2024 | Year | 03 | Month | 05 | Day |
Last modified on
| 2024 | Year | 03 | Month | 05 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000061379
| Research Plan | |
|---|---|
| Registered date | File name |
| Research case data specifications | |
|---|---|
| Registered date | File name |
| Research case data | |
|---|---|
| Registered date | File name |
